Hematology Oncology Consultants

Royal Oak, Michigan 48073

1 studies enrolling now · 4 studies all time

What they study most

Advanced Malignant Solid Tumor, Carcinoma, Non-Small Cell Lung, Carcinoma, Non-Small-Cell Lung, Hepatic Impairment, Lung Cancer, Metastatic Pancreas Adenocarcinoma, Neoplasms, Lung, Neoplasms, Pulmonary, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, Pancreatic Adenocarcinoma, Pancreatic Adenocarcinoma Metastatic

Studies at this site

• Expanded Access Program for Daraxonrasib (RMC-6236) in Previously Treated Metastatic Pancreatic Adenocarcinoma — Available (expanded access)
• A Study to Compare the Blood Levels and Safety of Tazemetostat in Participants With Advanced Cancer and Moderate/Severe Liver Impairment to Participants With Advanced Cancer and Normal Liver Function — Stopped early
• Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy — Stopped early
• Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy — Stopped early